CN Stock MarketDetailed Quotes

301230 PharmaResources

Watchlist
  • 28.25
  • +0.90+3.29%
Market Closed Apr 25 15:00 CST
3.94BMarket Cap231.56P/E (TTM)

About PharmaResources Company

The company was founded in 2007. With its advantages in pharmaceutical process technology, the company also provides customized production services for key intermediates of new drugs, as well as the development and production of specialty pharmaceutical intermediates with complex chemical structures and high synthesis difficulties. On October 18, 2022, it successfully issued A-shares and was listed on the GEM. The company's main business mainly covers drug discovery (CRO), process research and development (CRO/CDMO), and commercial production (including CMO). The company's main products are drug discovery, including pharmaceutical chemistry research, synthetic chemistry research and pharmacokinetics research, process research and development, including process chemistry and process development, and CMC research for APIs, commercial production including customized production of new drugs (CMO), and R&D, production and sales of independent generic drug products.

Company Profile

Short Name-A泓博医药
Symbol-A301230
Company NamePharmaResources (Shanghai) Co., Ltd.
Listing DateNov 1, 2022
Issue Price40.00
Shares Offered19.25M share(s)
FoundedDec 14, 2007
Legal RepresentativePING CHEN
General ManagerPING CHEN
Secretaryqiuli li
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Securities Representativeqiuli li
Legal CounselBeijing Jiayuan Law Firm
Employees552
Phone021-50720100
Office AddressBuilding 12, No. 59, Kaiqing Road, Pudong District, Shanghai
Zip Code201201
Registered AddressBuilding 23, No. 315 Qingda Road, Pudong District, Shanghai
Fax021-50720097-266
Emailinfo@pharmaresources.cn
Business License310115400237574
BusinessResearch, development, and transfer of proprietary technology for new drugs and related biotechnology, and provision of relevant technical services and consulting (projects requiring approval according to law can only be carried out after approval by relevant departments).

Company Executives

  • Name
  • Position
  • Salary
  • PING CHEN
  • Chairman, Directors, General Manager, Member of the Remuneration and Assessment Committee, Chairman of the Strategy and Investment Committee, Nomination Committee Members
  • 1.22M
  • rongchang an
  • Directors, Audit Committee Member
  • --
  • shengli jiang
  • Directors, Deputy General Manager, Member of the Strategy and Investment Committee
  • 857.70K
  • zheng fei
  • Directors
  • --
  • qidong you
  • Independent Directors, Member of the Strategy and Investment Committee, Chairman of the Nomination Committee
  • 180.00K
  • li cheng
  • Independent Directors, Nomination Committee Members, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
  • 180.00K
  • chunyang shao
  • Independent Directors, Audit Committee Member, Chairman of the Remuneration and Assessment Committee
  • 180.00K
  • qiuli li
  • Board Secretary, Securities Affairs Representative
  • --
  • guodong liu
  • Chairman of the Supervisory Board, Auditors
  • --
  • zeping liu
  • Auditors
  • --
  • xuejun dong
  • Auditors
  • 390.40K
  • ZHEN-WEI CAI
  • Deputy General Manager
  • 1.14M
  • haifeng li
  • Deputy General Manager
  • 1.33M
  • shicheng li
  • Chief Financial Officer
  • 552.70K
  • xiaojing he
  • Employee Supervisors
  • 473.10K
  • honghai li
  • Employee Supervisors
  • --